how much weight does semaglutide make you lose (Ozempic® & Wegovy®) Before and After Results: Loss Timelines (2026) I Lost 35lbs in 3

Although BMI is useful, it has limitations

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA, and currently in Phase 2 and Phase 3 clinical trials

Irregular Periods Infrequent, irregular, or prolonged menstrual cycles

GLP-1 medication has been shown to be effective in helping people lose weight

Their broad geographic reach enables pharmaceutical companies to seamlessly deploy blockbuster medications to local neighborhoods, driving record-breaking sales volumes for drugs such as Mounjaro and Wegovy

Wanner C, Inzucchi SE, Lachin JM et al